Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Fakhar Siddiqui, MD, MBA
Merck & Co., Inc.
Poster(s):
(678)
Changes in the
Clostridioides difficile
Infection (CDI) Treatment Pattern Pre-Post Clinical Guideline Update in 2021 and Variations across Hospitals
Thursday, October 12, 2023
12:15 PM – 1:30 PM
US ET
(2152) Activity of Imipenem/Relebactam Against Carbapenem-Resistant Non-
Morganellaceae
Enterobacterales (NME) in the United States – SMART 2019-2021
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2153) Addition of Relebactam Increases Susceptibility to Imipenem Alone against Class C β-lactamase-Positive Enterobacterales: Asia/Pacific SMART 2019-2021
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2154) Cross-resistance of Ceftolozane-Tazobactam and Imipenem-Relebactam Against Clinical
P. aeruginosa
Isolates from Bloodstream and Respiratory Tract Infections– SMART United States 2019-2021
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2155) Low prevalence of OXA-48-like carbapenemases and susceptibility to imipenem/relebactam among carbapenem-resistant non-
Morganellaceae
Enterobacterales isolates from Latin America – SMART 2018-2021
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
